Ms. Mullen is an Analyst at the Johns Hopkins Center for Health Security and a Research Associate at the Johns Hopkins Bloomberg School of Public Health. Her primary interests include health security policy, bioterrorism and chemical warfare preparedness and response measures, and mass gatherings.
Before joining the Center, Ms. Mullen worked in the Health Emergencies Programme (WHE) of the World Health Organization (WHO). She contributed to projects dedicated to improving international and national efforts to respond to chemical, biological, radiological, or nuclear deliberate events. This included the development and implementation of training modules and a complimentary assessment tool for the Joint External Evaluation (JEE) that enables member states to determine their level of readiness for chemical or biological deliberate events. In addition, Ms. Mullen contributed to the revision of Public Health Response to Biological and Chemical Weapons: WHO Guidance (2004).
Ms. Mullen earned an Emerging Leaders in Biosecurity fellowship through the Center for Health Security in 2018. She received a master’s of public health degree in epidemiology with a concentration in global health from the University of Texas Health Science Center in 2017. During her studies, Ms. Mullen worked for the Health Protection Surveillance Centre (HSPC), a program under the Irish Department of Health, on the development of an Irish National Screening Guideline for Hepatitis C Viral Disease (HCV). Ms. Mullen continued her research in HCV throughout her studies, and her thesis focused on HCV genotype 1 direct acting antivirals treatment success rates.
Ms. Mullen earned a BS in molecular and cell biology from Texas A&M University in 2015. During this time, she worked for the WHO supporting national ministries of health with their preparedness efforts for mass gatherings.